Visikol Multiplex Technology and the Drug Discovery Process
Carol Tomaszewski2022-01-21T13:23:27-05:00Consumers across the world benefit from having access to the safest and most advanced drug discovery system. Every country [...]
Multiplex Cell Painting Assay for Pathological Diagnosis of Cells
Carol Tomaszewski2022-05-13T14:59:46-05:00Many human diseases are caused by morphological, physiological or genetic changes in cells. The challenges of disease diagnosis include [...]
How Many Markers are the Right Amount for Multiplex Tissue Imaging?
Carol Tomaszewski2021-12-16T09:02:54-05:00In the last few years, there has been an explosion in the number of platforms for multiplex tissue imaging [...]
Clinical Implications of Multiplex Imaging
Griffin Ferrara2021-07-19T12:16:41-05:00In 2021, over 1,000,000 new cases of cancer and over 600,000 cancer deaths are projected to occur in the [...]
Using Immunohistochemistry and Multiplex Slide Labeling for Tumor Research
Griffin Ferrara2021-03-02T12:59:25-05:00Accurate prediction and prognosis as well as patient stratification for precision therapy are the most important and difficult issues [...]
High Content Screening for Immune Modulators
Griffin Ferrara2021-02-19T10:14:01-05:00Cancer immunotherapies that target T cells via the blockage of immune checkpoints are a promising approach for cancer treatment. [...]
Visikol uses Multiplex Imaging Tools in Partnership with Hackensack Meridian Health
Griffin Ferrara2020-12-08T10:03:38-05:00Tuberculosis (TB) is still one of the top ten leading causes of death globally. Although TB is both preventable [...]